C-Type Natriuretic Peptide Engrafted Antibodies


Ontology type: sgo:Patent     


Patent Info

DATE

2019-10-16T00:00

AUTHORS

BROCKSCHNIEDER DAMIAN , HUDSON LUCAS , NOACK CLAUDIA , TEBBE JAN , WALSH STUART , WILMEN ANDREAS , WUNDER FRANK

ABSTRACT

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "BROCKSCHNIEDER DAMIAN", 
        "type": "Person"
      }, 
      {
        "name": "HUDSON LUCAS", 
        "type": "Person"
      }, 
      {
        "name": "NOACK CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "TEBBE JAN", 
        "type": "Person"
      }, 
      {
        "name": "WALSH STUART", 
        "type": "Person"
      }, 
      {
        "name": "WILMEN ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "WUNDER FRANK", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11897-010-0016-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022530445", 
          "https://doi.org/10.1007/s11897-010-0016-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-10-16T00:00", 
    "description": "

The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.

", "id": "sg:patent.EP-3553079-A1", "name": "C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420044.6", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-3553079-A1" ], "sdDataset": "patents", "sdDatePublished": "2022-08-04T17:25", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/patent/patent_51.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-3553079-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-3553079-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

53 TRIPLES      14 PREDICATES      16 URIs      8 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-3553079-A1 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N88a1e01ee44043478e61d31b48fcd6ff
4 schema:citation sg:pub.10.1007/s11897-010-0016-6
5 schema:datePublished 2019-10-16T00:00
6 schema:description <p id="pa01" num="0001">The present invention relates to an antibody or a fragment thereof comprising at least one heterologous amino acid sequence incorporated within at least one CDR region of said antibody or fragment thereof, wherein said at least one heterologous amino acid sequence comprises an N-terminal linker sequence (Ntls), a C-Type Natriuretic Peptide (CNP) and a C-terminal linker sequence (Ctls). Optionally, at least a portion of said at least one CDR region is replaced by said at least one heterologous amino acid sequence incorporated therein. The present invention further relates to such antibody or fragment thereof for use in a method for treatment, a composition comprising such antibody or fragment thereof, a nucleic acid or a mixture of nucleic acids encoding such antibody or fragment thereof, a host cell comprising such nucleic acid or such mixture of nucleic acids and to a process for producing such antibody or fragment thereof.</p>
7 schema:name C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
8 schema:recipient grid-institutes:grid.420044.6
9 schema:sameAs https://app.dimensions.ai/details/patent/EP-3553079-A1
10 schema:sdDatePublished 2022-08-04T17:25
11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
12 schema:sdPublisher N9a374a98899546d1b8ee0e0980388dd2
13 sgo:license sg:explorer/license/
14 sgo:sdDataset patents
15 rdf:type sgo:Patent
16 N0fa77e801f1545299e98c6f4405b267c rdf:first N34b147329b1e4b2d969c28a7ce814817
17 rdf:rest Ne453c217f49f418985230af133db815c
18 N1d87ec9142f94fe583e975d9472575fa schema:name TEBBE JAN
19 rdf:type schema:Person
20 N34b147329b1e4b2d969c28a7ce814817 schema:name NOACK CLAUDIA
21 rdf:type schema:Person
22 N49d67e0c5b434c4f8ecab5beda2f14ee rdf:first Nd4722e0c27c145c59e8f65bf3c3f02e2
23 rdf:rest N0fa77e801f1545299e98c6f4405b267c
24 N5598aea6e1824737aad4e0cd4c33c805 schema:name WILMEN ANDREAS
25 rdf:type schema:Person
26 N71fb194fbfda4b95a4260010585c8b50 schema:name WUNDER FRANK
27 rdf:type schema:Person
28 N7a9025dea85b46a29dfb9bdd4bf9f854 rdf:first N5598aea6e1824737aad4e0cd4c33c805
29 rdf:rest Nd5143360878c4846bc68bb0de5388e43
30 N88a1e01ee44043478e61d31b48fcd6ff rdf:first Nf0510f1eb27d4dd8bf7b053bfa15b7a4
31 rdf:rest N49d67e0c5b434c4f8ecab5beda2f14ee
32 N9a374a98899546d1b8ee0e0980388dd2 schema:name Springer Nature - SN SciGraph project
33 rdf:type schema:Organization
34 Nb787b85167be4799af1da69110ecf475 schema:name WALSH STUART
35 rdf:type schema:Person
36 Nbfcb492c77524b56be5f194670fd724b rdf:first Nb787b85167be4799af1da69110ecf475
37 rdf:rest N7a9025dea85b46a29dfb9bdd4bf9f854
38 Nd4722e0c27c145c59e8f65bf3c3f02e2 schema:name HUDSON LUCAS
39 rdf:type schema:Person
40 Nd5143360878c4846bc68bb0de5388e43 rdf:first N71fb194fbfda4b95a4260010585c8b50
41 rdf:rest rdf:nil
42 Ne453c217f49f418985230af133db815c rdf:first N1d87ec9142f94fe583e975d9472575fa
43 rdf:rest Nbfcb492c77524b56be5f194670fd724b
44 Nf0510f1eb27d4dd8bf7b053bfa15b7a4 schema:name BROCKSCHNIEDER DAMIAN
45 rdf:type schema:Person
46 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
47 rdf:type schema:DefinedTerm
48 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 sg:pub.10.1007/s11897-010-0016-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022530445
51 https://doi.org/10.1007/s11897-010-0016-6
52 rdf:type schema:CreativeWork
53 grid-institutes:grid.420044.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...